Showing results (1411-1420 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|August 23, 2014
The humanistic burden of head and neck cancer: a systematic literature reviewErika Wissinger, Ingolf Griebsch, Juliane Lungershausen, et al.Pharmacoeconomics|August 23, 2014
Some inconsistencies in NICE's consideration of social valuesMike Paulden, James F O'Mahony, Anthony J Culyer, et al.Pharmacoeconomics|August 23, 2014
Bidirectional citation searching to completion: an exploration of literature searching methodsSebastian Hinde, Eldon SpackmanPharmacoeconomics|September 3, 2013
Ruxolitinib for the treatment of myelofibrosis: a NICE single technology appraisalRos Wade, Micah Rose, Aileen Rae Neilson, et al.Pharmacoeconomics|December 31, 2015
Cost Prediction Using a Survival Grouping Algorithm: An Application to Incident Prostate Cancer CasesEberechukwu Onukwugha, Ran Qi, Jinani Jayasekera, et al.Pharmacoeconomics|January 11, 2016
Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting AntiviralsJagpreet Chhatwal, Tianhua He, Maria A Lopez-OlivoPharmacoeconomics|September 21, 2015
Validation of the Hospital Episode Statistics Outpatient Dataset in EnglandJoanna C Thorn, Emma Turner, Luke Hounsome, et al.Pharmacoeconomics|October 9, 2015
National Database for Autism Research (NDAR): Big Data Opportunities for Health Services Research and Health Technology AssessmentNalin Payakachat, J Mick Tilford, Wendy J UngarPharmacoeconomics|January 29, 2016
Apremilast for the Treatment of Moderate to Severe Plaque Psoriasis: A Critique of the EvidenceSebastian Hinde, Ros Wade, Stephen Palmer, et al.Pharmacoeconomics|September 4, 2015
Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in ScotlandFlorian S Gutzwiller, Alena M Pfeil, Zanfina Ademi, et al.Pageof 336